HHS
publication date
Covid-19
Biden Releases a New Plan to Combat COVID, but Experts Say There's Still a Ways to GoBoth signs of progress and setbacks have cropped up along the way.
Revenue Cycle
MGMA Asks HHS to Delay No Surprises Act Implementation, EnforcementIt also says that group practices shouldn't be required to obtain information about out-of-network plans.
Covid-19
HHS Extends COVID-19 PHE Another 90 DaysHHS has promised to give states at least 60-days notice before lifting the PHE, which allows among other things waivers...
Strategy
As Congress Wrestles With Plans to Expand Medicare, Becerra Says Any One Will DoBecerra also said he will support efforts to bring down drug prices, including allowing importation from such countries as Canada...
Strategy
OIG Cites CMS for Poor Risk Assessments"CMS?s ERM process did not consider national security risks for any of CMS?s programs in accordance with federal requirements," the...
Strategy
Biden Order Pushes Competition, Targets Healthcare Consolidation, High Drug CostsThe executive order targets four areas "where lack of competition in healthcare increases prices and reduces access to quality care"...
Strategy
AHA, 340B Health Applaud SCOTUS Decision to Hear Medicare Cuts CaseThe AHA applauded the Supreme Court's announcement in a statement released Friday morning.
Strategy
California Lawmakers Push Feds to Allow a Therapy That Pays Meth Users to AbstainProviders worry that by paying patients they'll violate anti-kickback regulations and thus jeopardize their federal funding through Medicaid.
Payer
HHS Unveils Interim Final Rule for Surprise BillingThe Requirements Related to Surprise Billing; Part I , set to take effect on January 1, 2022, is the first...
Payer
AHA 'Disappointed' SCOTUS Won't Hear Site-Neutral Appeal The suit was in response to the 2018 site-neutral final rule that paid hospitals the same reimbursement for some inpatient...
Strategy
SCOTUS Upholds ACA in California v. Texas CaseIn a 7-2 decision, the Court ruled that the plaintiffs do not have standing to sue over the landmark healthcare...
Payer
OIG: Medicare Advantage Overpaid Anthem $3.5MAnthem disputed the findings and rejected the recommendations in its rebuttal of the report.